Big Pharma
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
Global biopharma M&A is experiencing a sharp uptick, putting the sector on track for its strongest year since the pre-pandemic peak seven years ago. Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking so far in 2026 amounted to $106 billion over 201 deals, according to PitchBook data. If the current pace of biopharma M&A holds up for the rest of the year, the industry could be on track to notch more than $250 billion in...
Platner’s anti-corporate crusade hits awkward snag as receipts tell another story
Maine Democratic Senate candidate Graham Platner built a national reputation as an anti-corporate crusader while cashing checks written by lobbyists and executives representing those same corporations, campaign finance documents show. Platner has made criticism of big tech, the pharmaceutical industry, large banks and defense contractors a cornerstone of his campaign to unseat incumbent GOP Sen. Susan Collins. Federal Election Commission and Lobbying Disclosure Act records reviewed by Fox...
Platner’s anti-corporate crusade hits awkward snag as receipts tell another story
Maine Democratic Senate candidate Graham Platner built a national reputation as an anti-corporate crusader while cashing checks written by lobbyists and executives representing those same corporations, campaign finance documents show. Platner has made criticism of big tech, the pharmaceutical industry, large banks and defense contractors a cornerstone of his campaign to unseat incumbent GOP Sen. Susan Collins. Federal Election Commission and Lobbying Disclosure Act records reviewed by Fox...
Trump-endorsed Hinson secures Iowa Senate nomination as Democrats eye GOP seat
Republican Rep. Ashley Hinson of Iowa on Tuesday captured her party's Senate nomination in the race to succeed retiring GOP Sen. Joni Ernst. Hinson, a former TV news anchor who is in her third term representing Iowa's 2nd Congressional District, defeated former state senator and former U.S. Senate candidate Jim Carlin in the GOP Senate primary, The Associated Press reported. The Republican-controlled seat in Iowa is a top target for Democrats, and the race is one of about a dozen crucial...
Trump-endorsed candidate stunned in Iowa as anti-pesticide movement claims major victory
Trump-endorsed candidate stunned in Iowa as anti-pesticide movement claims major victory The narrow win on Tuesday exposed potential vulnerabilities within Trump's coalition in the deeply conservative state, offering encouragement to Democrats who are optimistic about their chances of flipping the governor's office this year - Bookmark - CommentsGo to comments Businessman Zach Lahn delivered a significant upset in Iowa’s Republican gubernatorial primary, defeating Rep. Randy Feenstra, who...
Iowa Is Back on the Map
You could be forgiven for ignoring the recent political goings-on in Iowa. The state, which was once a violet-hued hub of unpredictability, has lately elected and reelected Republicans. In last night’s primaries, though, Iowa Democrats nominated the kind of candidates the national party has struggled to find.
Blue state governor roasted as ‘arsonist’ putting out her own fire as she blames outside agitators at 'siege'
As New Jersey Gov. Mikie Sherrill blamed out-of-state agitators for unrest outside Newark's Delaney Hall detention facility, critics pointed to the limited police presence around the site in the days leading up to the clashes. During Fox News Digital’s time on scene at Delaney Hall through Thursday of last week, there were few, if any, visits by marked New Jersey State Police vehicles — an agency under Sherrill’s control. Likewise, Newark Mayor Ras J. Baraka’s hands-off sanctuary city...
Life-saving breast cancer and endometriosis drug to be discontinued
AstraZeneca pulls critical breast cancer and endometriosis drug Zoladex from shelves Thu 4 Jun 2026 at 4:49am In short: AstraZeneca has announced it will pull a critical breast cancer and endometriosis drug from Australian shelves from November. Patients have labelled the decision "cruel" and say they have been blindsided. AstraZeneca says it will provide free access to the drug for six months for those without alternative treatment pathways.
How disinformation in Congo is worsening Ebola epidemic
How disinformation in Congo is worsening Ebola epidemic June 5, 2026Three weeks since the start of the latest Ebola epidemic in the Democratic Republic of Congo, the facts are: 397 confirmed cases, including 63 confirmed deaths, according to the latest figures reported by the African Union's Africa Centres for Disease Control and Prevention. And yet: "The community does not believe in this disease. Despite the deaths, people don't believe in it," said John Tumujimbe, head of a team for...
DRC: How disinformation worsens Ebola epidemic
DRC: How disinformation worsens Ebola epidemic June 5, 2026Three weeks since the current Ebola epidemic in the Democratic Republic of Congo was announced, the facts are: 397 confirmed cases, including 63 confirmed deaths, according to the latest figures reported by the African Union's Africa Centres for Disease Control and Prevention (Africa CDC). And yet: "The community does not believe in this disease. Despite the deaths, people don't believe in it," said John Tumujimbe, head of a team for...